Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors

INTRODUCTION: Studies on the effect of androgen receptor pathway inhibitors (ARPI), docetaxel (DTX), and radium-223 (Ra-223) after first-line treatment with ARPI in patients with castration-resistant prostate cancer (CRPC) are scarce. This study compared the efficacy of treatment after ARPI for CRPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Takashi, Shiota, Masaki, Yamada, Shigetomo, Blas, Leandro, Naganuma, Hidekazu, Lee, Ken, Monji, Keisuke, Kashiwagi, Eiji, Takeuchi, Ario, Inokuchi, Junichi, Shiga, Ken-ichiro, Yokomizo, Akira, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827108/
https://www.ncbi.nlm.nih.gov/pubmed/35224264
http://dx.doi.org/10.31662/jmaj.2021-0163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827108/
https://www.ncbi.nlm.nih.gov/pubmed/35224264
http://dx.doi.org/10.31662/jmaj.2021-0163

Ejemplares similares